人新基因hbrp的染色体定位及其对TPK活性的抑制作用（简报）

hbrp(Human BSP-Related Protein)是我们实验室最近在睾丸组织中克隆的一个人与BSP（bovine seminal plasma)蛋白相关的新基因。为了将有关该新基因信息与现有人类基因组转录图相整合,我们应用荧光原位杂交(fluorescent in situ hybridizationFISH)法进行了该基因的人染色体基因定位,结果成功地将hbrp基因定位在人19号染色体长臂1区3带上。hbrp基因是在对BSP蛋白功能的研究过程中发现并克隆的,其同源性分析发现,与其序列最相近     

抗冻蛋白结构与抗冻机制

抗冻蛋白(amifreeze proteins,AFPs)是20世纪60年代从极地鱼血淋巴中分离的一种大分子抗冻剂,迄今为止科学工作者已从陆地昆虫、植物、细菌和真菌等各类生物中分离到多种抗冻蛋白,并测得了它们的基因序列及一些晶体结构,近些年的工作主要集中在该类蛋白质抗冻机制的研究上。抗冻蛋白具有广泛的应用前景,它不但可以应用于食物的冷鲜贮存及移植器官的低温保存,还可通过转基因提高经济作物的抗冻能力。     

高致病性H5亚型禽流行性感冒病毒血凝素单克隆抗体的制备与初步应用

以禽流感病毒株Ck/HK/Yu22/02（H5N1）作为免疫原,利用常规杂交瘤技术和血凝抑制试验法成功地筛选出6株稳定分泌抗高致病性H5亚型禽流感病毒血凝素的单克隆抗体（单抗）,分别命名为2F2、3C8、3FC1、7C6、10HD4和13G4.经血凝抑制试验法分析,结果发现这6株单抗具有特异性高、反应性强、识别谱宽且互补等特点.基于单抗2F2,初步建立了三种H5N1病毒诊断方法,经评估证实均具有很好的特异性.由此说明,研究制备的抗H5亚型禽流感病毒血凝素单抗可适用于H5N1病毒的诊断.     

一种新型H5N1禽流感病毒血凝素抗原快速检测试剂的建立

利用5株广谱特异性抗H5亚型血凝素单克隆抗体和酶联免疫渗滤技术成功地建立了一种适于现场检测H5亚型禽流感病毒血凝素蛋白的抗原快速检测试剂H5-HA(Ag)Dot-ELISA。该试剂对41株代表当前亚洲地区流行的各种遗传变异亚系H5N1禽流感病毒检测均为阳性,对多数毒株的分析灵敏度优于0.1个血凝滴度(HA titer),其中部分优于0.01个血凝滴度;比较该试剂与早期开发的同类ELISA试剂,发现前者对后者未能检出的H5N1新变异株检测均为阳性;利用该试剂和商品化Directigen Flu A(BD)试剂检测两株H5N1病毒株,提示前者灵敏度高于后者;该试剂对一株H5N1病毒的检测灵敏度与标准RT-PCR相当;该试剂对24株非H5亚型病毒检测均为阴性,显示出良好特异性。以上结果提示,此研究建立的H5N1病毒抗原快速检测试剂在H5禽流感现场检测上具有较好的应用前景。     

假苍耳的生活史进程中几种生理生化指标的变化

本文试图从生理生化的角度对假苍耳(Iva xanthifolia)生活史进程中可溶性糖类、赤霉素、单宁以及黄酮的变化进行探讨。通过对假苍耳在生长发育期间几种生理生化指标的测定,结果表明,在假苍耳生活史进程的不同阶段,其体内各种代谢产物的含量基本都在种子或芽阶段具有最高含量。此外,不同发育阶段可溶性还原糖含量的变化规律相似：芽＞花序＞苗＞成株＞种子。除在花序和苗阶段没有测到海藻糖,其他各阶段海藻糖的含量变化如下：芽＞成株＞种子。另外,只有在种子阶段检测到棉子糖,其含量为15.43 mg·g~(-1)。赤霉素含量的变化规律如下：种子＞芽≈苗≈花序＞成株。单宁含量的变化趋势：种子＞成株＞苗＞芽＞花序。黄酮含量的变化趋势：种子＞芽＞成株≈花序＞苗。值得注意的是,当单宁/黄酮的比值接近1时,植物体内需要的单宁和黄酮的含量则相对较低;相反,当单宁/黄酮的比值接近0时,植物体内需要的单宁和黄酮的含量则较高。     

重金属铅对鲫鱼乳酸脱氢酶和过氧化氢酶活性的影响

在实验室条件下,采用毒性实验方法研究不同浓度重金属铅(Pb2 )对鲫鱼血清乳酸脱氢酶(LDH)和血液过氧化氢酶(CAT)活性的影响.研究结果表明,随着金属离子铅浓度的增高血清中乳酸脱氢酶和过氧化氢酶活性下降,但两种酶对铅离子影响的敏感程度不同.影响LDH活性的最低铅离子浓度为0.1mmol/L,而CAT为0.5mmol/L,当Pb2 浓度为1mmol/L时,LDH活性降至10%左右,而CAT仅下降50%左右.对重金属离子浓度与酶活性的定性和定量分析为有效监控鱼类生存环境提供了有价值的参考资料.     

光合细菌M-01的培养条件优化研究

对光合细菌M-01的培养条件进行了优化研究,结果表明:菌株的生长温度为30℃时,最适培养光照为3000lx,最低接种浓度为6%。培养基正交试验研究表明其最优培养基配方为:氯化铵2.00g,磷酸氢二钾0.20g,乙酸钠4.00g,碳酸氢钠2.00g,氯化钠1.00g,酵母膏0.15g,硫酸镁0.20g,T.M储液少量,蒸馏水1000mL;其中乙酸钠为最大影响因子。     

里氏木霉LW1固态发酵纤维素酶条件的研究

采用里氏木霉LW 1(Trichoderma.Reesei)固体发酵生产纤维素酶,研究了秸杆粉和麦麸用量、料水比、起始pH值、发酵温度和发酵时间对该菌株产纤维素酶活力的影响。试验结果表明,里氏木霉LW 1的适宜发酵条件为:在秸秆∶麦麸=1∶1,料水比为1∶2的前提条件下,培养温度28℃,发酵周期为72h,起始pH5.5时产酶活力最高。浸出液中FPA酶活为119.417u/g干物质,CMC酶活为452.433u/g干物质。     

Genetic Diversity and Core Collection Evaluations in Common Wheat Germplasm from the Northwestern Spring Wheat Region in China

Fluorescence microsatellite markers were employed to reveal genetic diversity of 340 wheat accessions consisting of 229 landraces and 111 modern varieties from the Northwest Spring Wheat Region in China. The 340 accessions were chosen as candidate core collections for wheat germplasm in this region. A core collection representing the genetic diversity of these accessions was identified based on a cluster dendrogram of 78 SSR loci. A total of 967 alleles were detected with a mean of 13.6 alleles (5–32) per locus. Mean PIC was 0.64, ranged from 0.05 to 0.91. All loci were distributed relatively evenly in the A, B and D wheat genomes. Mean genetic richness of A, B and D genomes for both landraces and modern varieties was B > A > D. However, mean genetic diversity indices of landraces changed to B > D > A. As a whole, genetic diversity of the landraces was considerably higher than that of the modern varieties. The big difference of genetic diversity indices in the three genomes suggested that breeding has exerted greater selection pressure in the D than the A or B genomes in this region. Changes of allelic proportions represented in the proposed core collection at different sampling scales suggested that the sampling percentage of the core collection in the Northwest Spring Wheat Region should be greater than 4% of the base collection to ensure that more than 70% of the variation is represented by the core collection. Electronic supplementary material Electronic supplementary material is available for this article at and accessible for authorised users.     

A novel compound derived from danshensu inhibits apoptosis via upregulation of heme oxygenase-1 expression in SH-SY5Y cells

Background

Heme oxygenase-1 (HO-1) has potential anti-apoptotic properties. A novel compound [4-(2-acetoxy-3-((R)-3-(benzylthio)-1-methoxy-1-oxopropan-2- ylamino)-3-oxopropyl)-1,2-phenylene diacetate (DSC)] was synthesized by joining danshensu and cysteine through an appropriate linker. This study investigated if the cytoprotective properties of DSC involved the induction of HO-1.

Methods

We evaluated the cytoprotective effects of DSC on H₂O₂-induced cell damage, apoptosis, intracellular and mitochondrial reactive oxygen species (ROS) production, mitochondrial membrane potential (ΔΨ_m) loss, and apoptosis-related proteins expression and its underlying mechanisms.

Results

DSC concentration-dependently attenuated cell death, lactate dehydrogenase release, intracellular and mitochondrial ROS production, and ΔΨ_m collapse, modulated apoptosis-related proteins (Bcl-2, Bax, caspase-3, p53, and cleaved PARP) expression, and inhibited phosphorylation of extracellular signal-regulated kinase 1/2 in SH-SY5Y cells induced by H₂O₂. In addition, DSC concentration-dependently induced HO-1 expression associated with nuclear translocation of nuclear factor-erythroid 2 related factor 2 (Nrf-2), while the effect of DSC was inhibited by a phosphoinositide 3-kinase (PI3K) inhibitor LY294002. Furthermore, the protective effect of DSC on H₂O₂-induced cell death was abolished by HO-1 inhibitor ZnPP, but was mimicked by carbon monoxide-releasing moiety CORM-3 or HO-1 by-product bilirubin. Finally, DSC inhibited H₂O₂-induced changes of Bcl-2, Bax, and caspase-3 expression, and all of these effects were reversed by HO-1 silencing.

Conclusions

Induction of HO-1 may be, at least in part, responsible for the anti-apoptotic property of DSC, an effect that involved the activation of PI3K/Akt/Nrf-2 axis.

General significance

DSC might have the potential for beneficial therapeutic interventions for neurodegenerative diseases.